Innovative Hematology, Inc. News

News

  • Home
  • News
  • Innovative Hematology Launches Indiana’s First Comprehensive Hemophilia Gene Therapy Hub

Innovative Hematology Launches Indiana’s First Comprehensive Hemophilia Gene Therapy Hub

Feb 5, 2026

Innovative Hematology, home to the Indiana Hemophilia & Thrombosis Center (IHTC), announces the launch of its Gene Therapy Hub—Indiana’s only comprehensive center providing on-site gene therapy for hemophilia. The Hub offers end-to-end care, including patient evaluation, infusion services, and long-term monitoring, bringing transformative treatment within reach for patients across Indiana and the surrounding region.

Transforming Care Through Gene Therapy

Hemophilia affects approximately 33,000 people in the U.S., with Hemophilia A occurring three to four times more frequently than Hemophilia B. The most common symptoms of hemophilia are bleeding into joints, prolonged bleeding from cuts or injuries, nosebleeds, and bruising. Symptoms vary depending on the severity of the disease.

Hemophilia management often involves frequent, expensive, and time-consuming infusions to replace missing clotting factor. Gene therapy offers a revolutionary approach: a one-time infusion designed to restore clotting factor production and dramatically reduce bleeding episodes. Available gene therapies offer as much as ~90% reduction in annual bleeds.

“Hemophilia gene therapy represents a paradigm shift – moving patients from a lifetime of replacement therapy to an opportunity to live life unencumbered by their bleeding disorder,” says Dr. Amy Shapiro, CEO and cofounder of Innovative Hematology and the IHTC.

Comprehensive Support for Providers and Patients

Innovative Hematology’s Gene Therapy Hub offers:

  • 20 expert hematologists supported by multidisciplinary clinicians
  • State-of-the-art infusion facilities
  • End-to-end care coordination including prior authorizations, patient education, and post-infusion monitoring

Partner With Us

Innovative Hematology collaborates with referring providers to ensure seamless hematology care with the whole patient in mind. Our team manages assessments, billing, and follow-up, so patients and providers can focus on outcomes.

Contact:
Phone: 317-871-0000
Email: [email protected]
Website: innovativehematology.org/genetherapyinfo
Address: 8326 Naab Road, Indianapolis, IN 46260

Our Recent News

Letter from Chair of the Board

Letter from Chair of the Board

The Innovative Hematology Board of Directors appointed Sanjay P. Ahuja, MD, MSc, MBA as Chief Executive Officer & Medical Director of Innovative Hematology, effective April 1, 2026

Connect

Innovative Hematology, Inc.
8326 Naab Road
Indianapolis, IN 46260

317-871-0000
877-CLOTTER (877-256-8837)
317-871-0010 (fax)